Certifect
Withdrawn
This medicine's authorisation has been withdrawn
fipronil / amitraz / (S)-methoprene
MedicineVeterinaryWithdrawn
Finnish is available via eTranslation, the European Commission's machine translation service.
Translate to Finnish | Important information about machine translation
- Application under evaluation
- CVMP opinion
- European Commission decision
Overview
The marketing authorisation for Certifect has been withdrawn at the request of the marketing-authorisation holder.
Product information
Latest procedure affecting product information:R/0011
18/04/2016
Product details
- Name of medicine
- Certifect
- Active substance
- fipronil
- amitraz
- (S)-methoprene
- International non-proprietary name (INN) or common name
- fipronil / amitraz / (S)-methoprene
- Species
- Dogs
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QP53AX65
Pharmacotherapeutic group
Ectoparasiticides for topical use, incl. insecticidesTherapeutic indication
Treatment and prevention of infestations in dogs by ticks (Ixodes ricinus, Dermacentor reticulatus, Rhipicephalus sanguineus, Ixodes scapularis, Dermacentor variabilis, Haemaphysalis elliptica, Haemaphysalis longicornis, Amblyomma americanum and Amblyomma maculatum) and fleas (Ctenocephalides felis and Ctenocephalides canis). Treatment of infestations by chewing lice (Trichodectes canis). Prevention of environmental flea contamination by inhibiting the development of all flea immature stages. The product can be used as part of a treatment strategy for the control of flea-allergy dermatitis. Elimination of fleas and ticks within 24 hours. One treatment prevents further infestations for five weeks by ticks and for up to five weeks by fleas.
The treatment indirectly reduces the risk of transmission of tick-borne diseases (canine babesiosis, monocytic ehrlichiosis, granulocytic anaplasmosis and borreliosis) from infected ticks for four weeks.
News on Certifect
This page was last updated on